Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,460.00
(
0.21%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
-2.17%
)
Bitcoin
72,881.00
(
1.53%
)
News Focus
News Focus
Post# of 3757
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122860
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: gofishmarko post# 1402

Thursday, 07/19/2007 6:16:07 PM

Thursday, July 19, 2007 6:16:07 PM

Post# of 3757
>Having Anna Lok say that Tyzeka has "a limited role in HBV monotherapy"…<

The same kinds of remarks were made about Baraclude circa 2005—I heard them myself on the Q&A at BMY’s CC’s. But look at how Baraclude is doing now—not bad.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote